Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial

Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page version/revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor interface or system update without changing the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:32:26.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision v3.5.2 has been added and the previous revision v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:07.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    A new record version v3.5.0 was added and the previous version v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:55.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history, replacing the previous v3.4.2 entry in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T01:05:12.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 banner on the page. Removed notices about government funding/operating status and the previous v3.4.1 revision.
    Difference
    0.7%
    Check dated 2026-02-11T12:12:04.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a site-wide funding/operating status notice. Updated the history version from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-04T06:49:26.000Z thumbnail image

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.